Shoos Karen L. Insider Trades

Insider Trading History

Track insider trading activity for Shoos Karen L.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $494k 16,500 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$601k 16,500 shares
$36.43
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $338k 11,300 shares
Last Trade
Jun 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$417k 11,300 shares
$36.87
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $407k 13,600 shares
Last Trade
Jun 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$306k 13,600 shares
$22.48
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $359k 12,000 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$336k 12,000 shares
$28.00
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $329k 11,000 shares
Last Trade
Jun 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$114k 11,000 shares
$10.38
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $135k 4,500 shares
Last Trade
Jun 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.5k 4,500 shares
$2.78
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Director
Holding Value $2.01M 67,000 shares
Last Trade
Jun 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$604k 67,000 shares
$9.02
$29.93

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up